Shares of IQVIA Holdings Inc. IQV slid 2.81% to $148.99 Friday, on what proved to be an all-around grim trading session for ...

Q1 2025 Earnings Call Transcript May 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $2.7, ...

Shares of IQVIA Holdings Inc. rose 4.86% to $153.30 Wednesday, on what proved to be an all-around positive trading session ...

IQVIA Holdings (NYSE:IQV) recently reported their Q1 earnings with a beat on normalized EPS and revenue despite the challenges of navigating a very cautious healthcare sector. IQV has been one of ...

Full Year Adjusted Diluted EPS Guidance: $11.70 to $12.10. IQVIA Holdings Inc (NYSE:IQV) delivered strong revenue and profit results at the high end of expectations, with total revenue for the ...

IQVIA Holdings (IQV) reported $3.83 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 2.5%. EPS of $2.70 for the same period compares to $2.54 a year ago.

The clinical testing company posted revenue of $3.83 billion in the period, which also beat Street forecasts. Nine analysts surveyed by Zacks expected $3.77 billion. IQVIA expects full-year earnings ...

This was the stock's second consecutive day of losses.